First Time Loading...

Taro Pharmaceutical Industries Ltd
NYSE:TARO

Watchlist Manager
Taro Pharmaceutical Industries Ltd Logo
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Watchlist
Price: 42.4 USD -0.19% Market Closed
Updated: Apr 28, 2024
TARO
/
Cash Flow Statement
/
Cash from Operating Activities

Taro Pharmaceutical Industries Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Taro Pharmaceutical Industries Ltd
Cash from Operating Activities Peer Comparison

Comparables:
T
TEVA
I
INCR
MDWD
R
REKA
C
CSURE

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Cash from Operating Activities
$142.9m
CAGR 3-Years
48%
CAGR 5-Years
-17%
CAGR 10-Years
-9%
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Cash from Operating Activities
$1.4B
CAGR 3-Years
4%
CAGR 5-Years
-11%
CAGR 10-Years
-8%
I
InterCure Ltd
TASE:INCR
Cash from Operating Activities
-₪3.4m
CAGR 3-Years
40%
CAGR 5-Years
-27%
CAGR 10-Years
-2%
Mediwound Ltd
NASDAQ:MDWD
Cash from Operating Activities
-$10.5m
CAGR 3-Years
-15%
CAGR 5-Years
3%
CAGR 10-Years
-1%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Cash from Operating Activities
₪30.7m
CAGR 3-Years
28%
CAGR 5-Years
22%
CAGR 10-Years
15%
C
Cannassure Therapeutics Ltd
TASE:CSURE
Cash from Operating Activities
-₪7.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Taro Pharmaceutical Industries Ltd's Cash from Operating Activities?
Cash from Operating Activities
142.9m USD

Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Cash from Operating Activities amounts to 142.9m USD.

What is Taro Pharmaceutical Industries Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-9%

Over the last year, the Cash from Operating Activities growth was 771%. The average annual Cash from Operating Activities growth rates for Taro Pharmaceutical Industries Ltd have been 48% over the past three years , -17% over the past five years , and -9% over the past ten years .

ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.